Level B· Emerging clinical evidence with positive signalsClinical TrialPubMed

[Different sources of mesenchymal stem cells for the treatment of cartilage repair in knee joint].

Wang L., Hou P., Jiang T., Wang ZB., Zhao YX., Wu K.

Clinical Trial on Cartilage Damage, published in Zhongguo Gu Shang (2017) — summary generated from the PubMed abstract.

Open my reading list
Level B· Emerging clinical evidence with positive signalsEvidence level of this study

Several human studies show positive signals, while research methods and sample sizes continue to develop.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Clinical Trial
Journal
Zhongguo Gu Shang (2017)
Country
China
Reported sample size
—
Source database
PubMed
PMID
29424184
DOI
10.3969/j.issn.1003-0034.2017.06.020

Abstract (original English)

As propose of organ repair stem cell therapy technology, articular cartilage cannot be repaired by itself has become one of the research hotspots, repair of articular cartilage with mesenchymal stem cells has shown obvious advantages for the treatment. The scholars have made a preliminary study on the role of mesenchymal stem cells from different sources in the repair of knee articular cartilage, and with the combination of transplantation and cartilage tissue engineering, these technologies improved the human cartilage repair effect of bone marrow, adipose, synovium, cord blood derived stem cells, which achieved good clinical curative effect. Due to the different sources, the dominant and recessive factors, each stem cell will have certain advantages and disadvantages. At present, the clinical research is still in the experimental stage, there is no definite conclusion on which kind of stem cell or technology is more suitable for human cartilage repair. This requires the validation of large-scale or combining with new processing technology clinical trials and the long-term clinical effect, it also provides for the basis for further clinical research.

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.

Evidence level

Several human studies show positive signals, while research methods and sample sizes continue to develop.

How we grade evidence
Adipose TissueBone Marrow CellsCartilage, ArticularFetal BloodHumansKnee JointMesenchymal Stem Cell TransplantationMesenchymal Stem CellsSynovial MembraneTissue Engineering

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research